Computational and Quantitative Medicine Faculty

Suzette Blanchard, Ph.D., is a biostatistician and associate research professor in the Division of Biostatistics within the Department of Computational and Quantitative Medicine.

Dr. Branciamore's research interests include (i) investigating the impact of epigenetics on development, disease and evolution, (ii) the application of methods from statistical mechanics and dynamical systems to personalized medicine for the treatment of complex diseases and cancer, and (iii) the

Benjamin Djulbegovic, M.D., Ph.D., main academic and research interest lies in attempts to measure and optimize clinical research and practice of medicine by understanding both the nature of medical evidence and decision-making.

Paul Frankel, Ph.D., is is a scientist in the biostatistics division of the Department of Computational and Quantitative Medicine.

Dr. Gu’s research focus is to integrate multi-omics platforms, advanced analytical approaches, and multiple experimental models to study the heterogeneity of acute leukemias and facilitate the development of more efficacious targeted therapies.

Dr. Lacey studies women’s cancer risks and outcomes. He is a principal investigator of the California Teachers Study cancer epidemiology cohort, and he leads innovative initiatives to improve transparency, efficiency and data-sharing in population sciences.

Dr. Palmer’s research interests and effort support preclinical and clinical studies concerning the major obstacles to disease control/cure of hematologic malignancies and successful hematopoietic stem cell transplantation.

Dr. Rockne serves as director of the Division of Mathematical Oncology and Computational Systems Biology, with the goal of translating mathematics, physics and evolution-based research to clinical care.

Andrei S. Rodin, Ph.D., research interests are (i) computational systems biology — both methodology development and application to diverse high-dimensional multiscale biomedical data, and (ii) molecular evolution.

Cristian Tomasetti, Ph.D., is the director of City of Hope's Center for Cancer Prevention and Early Detection, director of the Division of Mathematics for Cancer Evolution and Early Detection in the Department of Computational and Quantitative Medicine at Beckman Research Institute of City of Hope

Nagarajan Vaidehi, Ph.D., is a scientist, educator and leader with a career-long commitment to developing computational methods to simulate dynamics of proteins involved in signal transduction pathways and using them for the discovery of next generation drugs with lower side effects. Dr. Vaidehi is

Dr. Wang is a molecular epidemiologist whose multifaceted research spans the evaluation of genes and heritability, the physical and social environment, and their interactions in cancer and cardiovascular disease etiologies, leveraging data from large cohort and international consortia.

Dr. Wu’s research interests are in development and application of innovative state-of-the-art bioinformatics techniques and tools that span basic and translational research areas pertaining to genome technologies.

Yate-Ching Yuan, Ph.D., is an associate research professor in the Division of Research Informatics in the Center for Informatics of City of Hope.